These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25759633)

  • 61. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reduced phenotypic expression in genetic hemochromatosis with time: Role of exposure to non-genetic modifiers.
    Deugnier Y; Morcet J; Lainé F; Hamdi-Roze H; Bollard AS; Guyader D; Moirand R; Bardou-Jacquet E
    J Hepatol; 2019 Jan; 70(1):118-125. PubMed ID: 30244162
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [A young diabetic with small-nodule liver cirrhosis, high transferrin saturation and negative HFE test].
    Eisold M; Gehrke S; Stremmel W; Gugler R
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1494-6. PubMed ID: 15942838
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hereditary hemochromatosis in children, adolescents, and young adults.
    Haddy TB; Castro OL; Rana SR
    Am J Pediatr Hematol Oncol; 1988; 10(1):23-34. PubMed ID: 3056060
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Management of cardiac hemochromatosis.
    Aronow WS
    Arch Med Sci; 2018 Apr; 14(3):560-568. PubMed ID: 29765443
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Diagnosis and treatment of genetic hemochromatosis].
    Moirand R; Guillygomarc'h A; Brissot P; Deugnier Y
    Rev Prat; 2000 May; 50(9):977-82. PubMed ID: 10865497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Involvement and role of iron in nonalcoholic steatohepatitis].
    Cojocariu C; Trifan A; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):308-12. PubMed ID: 19294996
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hyperferritinemia in a kidney transplant recipient.
    Furić-Cunko V; Basić-Jukić N; Jurić I; Kes P
    Acta Clin Croat; 2011 Jun; 50(2):245-8. PubMed ID: 22263390
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Non-HFE-related hereditary iron overload].
    Aguilar-Martinez P
    Presse Med; 2007 Sep; 36(9 Pt 2):1279-91. PubMed ID: 17540536
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Usefulness and limitations of laboratory and hepatic imaging studies in iron-storage disease.
    Bonkovsky HL; Slaker DP; Bills EB; Wolf DC
    Gastroenterology; 1990 Oct; 99(4):1079-91. PubMed ID: 2394329
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diagnosis of hyperferritinemia in routine clinical practice.
    Lorcerie B; Audia S; Samson M; Millière A; Falvo N; Leguy-Seguin V; Berthier S; Bonnotte B
    Presse Med; 2017 Dec; 46(12 Pt 2):e329-e338. PubMed ID: 29150231
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Dysmetabolic hepatosiderosis, characteristics in 51 patients].
    Vénat L; Loustaud-Ratti V; Liozon E; Soria P; Nadalon S; Gissot V; Labrousse F; Vidal E
    Presse Med; 2003 Mar; 32(9):400-5. PubMed ID: 12712916
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Generalized pruritus as a symptom of hyperferritinemia: A case report and review of the literature.
    Osman S; Haber RM
    SAGE Open Med Case Rep; 2022; 10():2050313X221131861. PubMed ID: 36274857
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Assessment of plasma catecholamines in patients with dysmetabolic iron overload syndrome.
    Hanna HWZ; Baz HN; Al-Kzayer LFY; El Haddad HE; El-Mougy F
    J Appl Biomed; 2022 Dec; 20(4):141-145. PubMed ID: 36708719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.